Committee on Immunology, University of Chicago, Chicago, IL, USA.
Department of Medicine, University of Chicago, Chicago, IL, USA.
Nat Commun. 2020 May 11;11(1):2354. doi: 10.1038/s41467-020-15545-w.
Death due to sepsis remains a persistent threat to critically ill patients confined to the intensive care unit and is characterized by colonization with multi-drug-resistant healthcare-associated pathogens. Here we report that sepsis in mice caused by a defined four-member pathogen community isolated from a patient with lethal sepsis is associated with the systemic suppression of key elements of the host transcriptome required for pathogen clearance and decreased butyrate expression. More specifically, these pathogens directly suppress interferon regulatory factor 3. Fecal microbiota transplant (FMT) reverses the course of otherwise lethal sepsis by enhancing pathogen clearance via the restoration of host immunity in an interferon regulatory factor 3-dependent manner. This protective effect is linked to the expansion of butyrate-producing Bacteroidetes. Taken together these results suggest that fecal microbiota transplantation may be a treatment option in sepsis associated with immunosuppression.
死亡由于脓毒症仍然是一个持久的威胁,危重病人限制在重症监护病房,并以定植与多药耐药的医疗保健相关的病原体。在这里,我们报告说,由一个定义的四成员病原体社区从一个致命的脓毒症患者分离引起的脓毒症在小鼠与全身抑制的关键元素的宿主转录组所需的病原体清除和减少,但丁酸的表达。更具体地说,这些病原体直接抑制干扰素调节因子 3。粪便微生物群移植(FMT)通过恢复干扰素调节因子 3 依赖的宿主免疫来增强病原体清除,从而逆转否则致命的脓毒症的病程。这种保护作用与丁酸产生的拟杆菌的扩张有关。总之,这些结果表明粪便微生物群移植可能是与免疫抑制相关的脓毒症的一种治疗选择。